During the 8th Microbiome Movement – Drug Development Summit, held in London at the end of January, MicrobiomePost discussed with Isabelle de Cremoux, CEO of Seventure Partners, a leading venture capital firm in Europe, about the first fecal microbiota product approved by FDA and the news that will emerge in 2023.